Disseminated Acanthamoeba Infection in a Patient with AIDS: Response to 5-Fluorocytosine Therapy
Free-living amebas belonging to the genera Naegleria, Acanthamoeba, and Balamuthia are pathogenic protozoa for humans and animals. Acanthamoeba species and Balamuthia mandrillaris are opportunistic pathogens that cause infections involving preferentially the skin, sinuses, and CNS (granulomatous amebic encephalitis) [1] . These infections occur mainly in immunocompromised patients, particularly those with advanced HIV infection. This report describes a patient with AIDS who had cutaneous and sinus infections due to Acanthamoeba. The original aspect was a protracted clinical course related to medical treatment.
A 29-year-old woman was found to be seropositive for HIV type 1 (via heterosexual transmission) in 1992. Between 1992 and 1995, her medical history included oral candidiasis, pulmonary tuberculosis, herpes zoster, B cell non-Hodgkin's lymphoma of a tonsil, tonsillar actinomycosis, and chronic sinusitis with recurrent epistaxis. In June 1995, 3 months after a trip to Thailand, she developed three cutaneous nodules on the left thigh without fever or weight loss (her weight, 50 kg). Therapy at that time included zidovudine (400 mg/d) and trimethoprim-sulfamethoxazole (80/400 mg/d). One month later, new skin lesions (painful, nontender, erythematous, purplish papules and nodules ranging from a few millimeters to several centimeters in diameter) appeared on all four extremities. Some of the lesions became ulcerated and crusted (figure 1). Differential diagnosis included cryptococcal dermatitis and Penicillium marneffei infection.
Laboratory studies showed a WBC count of 2.9 ϫ 10 9 /L and a CD4 cell count of 2 ϫ 10 6 /L. No microorganisms were observed in cultures of blood, urine, and smear of a skin ulcer. A biopsy specimen from the cutaneous nodule was stained with periodic acid-Schiff and hematoxylin-eosin stains. Examination revealed a polymorphous inflammatory infiltrate and necrotizing vasculitis. A multinucleated giant cell was noted (unpublished data, A. J. Martinez). Some round structures were observed with a dense central nucleolus, a less dense nucleus, and a thick, well-stained wall. The presence of trophozoites and cysts of free-living amebas was suggested.
Cultures of skin biopsy samples inoculated on nonnutriment agar plates coated with Escherichia coli yielded marked growth of free-living amebas, both trophozoite and cyst forms. Immunofluorescence testing of the skin biopsy samples confirmed the presence of free-living amebas of the genus Acanthamoeba (unpublished data, G. S. Visvesvara). MRI of the head showed pansinusitis. CSF examination revealed a protein level of 0.83 g/L.
Treatment was started in August 1995 with the combination of 5-fluorocytosine (7.5 g/d intravenously) and itraconazole (400 mg/d orally). Marked improvement in the skin lesions was noted from the first week of treatment. On the 15th day of treatment, 5-fluorocytosine was discontinued because of hematologic toxicity. After 13 days of monotherapy with itraconazole, new skin nodules and ulcers appeared. Administration of 5-fluorocytosine (10 g/d) was resumed orally, resulting in improvement in the skin lesions in 1 week.
Noncompliance with oral medications during October 1995 was associated with the appearance of new skin lesions. A new multidrug regimen was started in December 1995 with the combination of itraconazole (400 mg/d orally) and pentamidine (150 mg/d for 5 days and then 300 mg/d for 6 days intramuscularly). No improvement was observed. The initial therapeutic regimen (5-fluorocytosine plus itraconazole) was administered again. Following this therapy, the course of the acanthamoeba infection altered with improvement and worsening. A granular lesion was also noted on the wall of the right nasal fossa (biopsy was refused). Parasitological examination revealed free-living amebas in purulent discharge from the left maxillary sinus in February 1996. The patient died of inanition in July 1996 after 1 year of acanthamoeba infection without clinical or radiological signs of CNS involvement; autopsy was not performed.
Disseminated infections with free-living amebas in patients with HIV infection are infrequent. As of 1 October 1996, 103 cases of disseminated acanthamoeba infection had been reported worldwide [1] . Of these 103 cases, 72 were from the United States alone (including Ͼ50 cases in patients with AIDS). This infection is usually associated with a poor prognosis. Our report documents a prolonged clinical course of cutaneous and sinus infections due to Acanthamoeba in a patient with AIDS. The successive therapeutic regimens demonstrate the transient efficacy of 5-fluorocytosine. Pentamidine (in association with itraconazole) did not show efficacy against the skin lesions.
Previous reports showed variability in the activity of 5-fluorocytosine, pentamidine, and itraconazole against different Acanthamoeba strains [2] [3] [4] [5] [6] . Furthermore, acquired resistance of Acanthamoeba to 5-fluorocytosine was suggested by different in vitro studies and other case reports [7] [8] . 5-Fluorocytosine should be included in chemotherapy for disseminated infections due to free-living amebas in combination with other antiamebic agents. To our knowledge, no case of defined clinical infection by the Centers for Disease Control and Prevention (CDC) Group O1 bacterium has been reported. Herein, we report a case of bacteremia and necrotizing pneumonia caused by this organism.
A 59-year-old man with a history of Crohn's disease, ankylosing spondylitis, and alcohol abuse was admitted to the hospital with a sudden, spontaneous loss of lower extremity strength and sensation. A motor and sensory cord level deficit was apparent at the T5 through T6 level, and an MRI demonstrated an epidural hematoma compressing the spinal cord between C5 and T11. The paralysis and sensory deficits resolved gradually over 24 hours.
A witnessed aspiration event occurred 3 days after admission.
The patient's condition rapidly deteriorated, and he required intubation; however, extubation could be performed within 72 hours.
A chest radiograph at intubation revealed a right lower lobe infiltrate; a large right pleural effusion developed over the next 5 days. Fever appeared at the time of extubation. Gram staining of sputum revealed gram-negative coccobacillary forms although routine cultures were negative. Cultures of blood obtained simultaneously yielded CDC Group O1 bacteria. Therapy with levofloxacin and piperacillin/tazobactam was initiated. The subsequent hospital course was difficult, marked by the development of a right hydropneumothorax with a bronchopleural fistula that resolved with chest tube placement. Gram staining and culture of the pleural fluid (obtained 5 days after initiation of antibiotic therapy) were negative. The WBC count peaked at 19,000/mm 3 several days after chest tube removal, but gradual defervescence and return of the WBC count to normal then occurred. Intravenous antibiotics were given for a total of 16 days in the hospital followed by an outpatient course of oral levofloxacin and clindamycin for 42 days. Follow-up chest radiographs demonstrated stabilization of his condition, and he was doing well 1 year later.
The gram-negative bacterial strain isolated from blood culture and presumably seen on gram staining of sputum was analyzed at the Texas State Department of Health (Austin, TX). The organism was a motile aerobe possessing one to two polar flagella and showed very light growth of 1-mm yellow colonies on plates of both blood agar and trypticase soy agar. It did not grow on 
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